Search research articles
Contact Us
Filters
Showing results (71-80 of 4,670) with videos related to
Page
of 467
Sort By:
Cancer Discovery
|
May 4, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
Otto Metzger Filho, Giuseppe Viale, Shayna Stein, et al.
Cancer Discovery
|
May 5, 2021
Bispecific Antibodies to PD-1 and CTLA4: Doubling Down on T Cells to Decouple Efficacy from Toxicity
Elizabeth M Burton, Hussein A Tawbi
Cancer Discovery
|
May 5, 2021
Cholangiocarcinoma Risk Factors Open the Floodgates for Gut Microbes and Immunosuppressive Myeloid Cells
Sharmeen Chagani, Lawrence N Kwong
Cancer Discovery
|
May 5, 2021
Retraction: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women
Kotha Subbaramaiah, Patrick G Morris, Xi Kathy Zhou, et al.
Cancer Discovery
|
April 29, 2021
Broadening Trial Eligibility Doesn't Weaken Results
Cancer Discovery
|
April 30, 2021
Antisense Oligos May Hit "Undruggable" YAP1
Cancer Discovery
|
May 15, 2021
STAG2 Promotes Anchored Loop Extrusion to Modulate EWSR1-FLI1 Activity
Cancer Discovery
|
May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
Emily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Cancer Discovery
|
May 15, 2021
Tumor Immunity and Immunotherapy for HPV-Related Cancers
Achraf A Shamseddine, Bharat Burman, Nancy Y Lee, et al.
Cancer Discovery
|
May 15, 2021
Blood Cancers Diminish Response to COVID-19 Vaccine
Page
of 467
Search research articles
Search
Showing results (71-80 of 4,670) with videos related to
Sort By:
Page
of 467
Cancer Discovery
|
May 4, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
Otto Metzger Filho, Giuseppe Viale, Shayna Stein, et al.
Cancer Discovery
|
May 5, 2021
Bispecific Antibodies to PD-1 and CTLA4: Doubling Down on T Cells to Decouple Efficacy from Toxicity
Elizabeth M Burton, Hussein A Tawbi
Cancer Discovery
|
May 5, 2021
Cholangiocarcinoma Risk Factors Open the Floodgates for Gut Microbes and Immunosuppressive Myeloid Cells
Sharmeen Chagani, Lawrence N Kwong
Cancer Discovery
|
May 5, 2021
Retraction: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women
Kotha Subbaramaiah, Patrick G Morris, Xi Kathy Zhou, et al.
Cancer Discovery
|
April 29, 2021
Broadening Trial Eligibility Doesn't Weaken Results
Cancer Discovery
|
April 30, 2021
Antisense Oligos May Hit "Undruggable" YAP1
Cancer Discovery
|
May 15, 2021
STAG2 Promotes Anchored Loop Extrusion to Modulate EWSR1-FLI1 Activity
Cancer Discovery
|
May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
Emily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Cancer Discovery
|
May 15, 2021
Tumor Immunity and Immunotherapy for HPV-Related Cancers
Achraf A Shamseddine, Bharat Burman, Nancy Y Lee, et al.
Cancer Discovery
|
May 15, 2021
Blood Cancers Diminish Response to COVID-19 Vaccine
Page
of 467